Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure
Full Press Release from Biofourmis
BOSTON, July 29, 2021
News Type: Healthcare
These 4 Singaporean companies are changing healthcare as we know it
These 4 Singaporean companies are changing healthcare as we know it
MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support
MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support
